International Journal of Drug Regulatory Affairs
  • Year: 2020
  • Volume: 8
  • Issue: 2

Procedure to submit an expression of interest (eoi) for product evaluation to expert review panel (erp) prequalification team: World Health Organization (WHO), Geneva

Manager - Drug Regulatory Affairs, Ravian Lifescience Pvt. Ltd., Sidcul, Haridwar, Uttarakhand, India, 249403

*Corresponding author Tel.: +91-9816777889, +91-8126534339, E-mail address: shrikantgodiyal1988@gmail.com (Shrikant Godiyal)

Online published on 24 May, 2021.

Abstract

Expression of Interest is an Application which is submitted for Product Evaluation to the Expert Review Panel Prequalification Team World Health Organization (WHO) which evaluates the application along with the supporting documents and ensures that the Active Pharmaceutical Ingredients (API’s) and Finished Pharmaceutical Products (FPPs) are safe to use and all the studies w.r.t the safety and efficacy of the product had been completed.

Keywords

World Health Organization (WHO), Expert Review Panel (ERP), Expression of Interest (EOI), Prequalification, Dossier